首页> 外国专利> a pharmaceutical composition for the treatment of tuberculosis and diseases, indirect HELICOBACTER PILORI, based on very solid lipid, and method of treating tuberculosis and

a pharmaceutical composition for the treatment of tuberculosis and diseases, indirect HELICOBACTER PILORI, based on very solid lipid, and method of treating tuberculosis and

机译:用于治疗结核病和疾病的药物组合物,基于非常固体脂质的间接幽门螺杆菌,以及治疗结核病的方法

摘要

the present invention relates to the field of medicine and pharmacy, more specific drugs for the treatment of tuberculosis.more specifically, to a pharmaceutical composition for the treatment of tuberculosis, based on dispersed in the u0444u0430u0440u043cu0430u0446u0435u0432u0442u0438u0447u0435u0441u043au0438 acceptable medium of solid lipid u043du0430u043du043eu0447u0430 stitz,the effective amount of an anti tuberculosis drug containing u0442u0435u0440u0430u043fu0435u0432u0442u0438u0447u0435u0441u043au0438 means (an antibiotic selected from the u0440u0438u0444u0430u0431u0443u0442u0438u043du0430 or u0440u0438u0444u0430u043cu043fu0438u0446u0438u043du0430), u0441u043eu0440u0431u0438u0440 u043eu0432u0430u043du043du043eu0433u043e in the lipid matrix.a lipid matrix such u043du0430u043du043eu0447u0430u0441u0442u0438u0446u044b contain a combination of one or more u0434u043bu0438u043du043du043eu0446u0435u043fu043eu0447u0435u0447u043du044bu0445 complex esters of fatty acids.cholesterol or its derivative and u0444u043eu0441u0444u043eu043bu0438u043fu0438u0434u0430 u0444u0430u0440u043cu0430u0446u0435u0432u0442u0438u0447u0435u0441u043au0438 acceptable.the invention relates to a method of treatment of tuberculosis, including the introduction of the pharmaceutical composition on the basis of solid lipid were sold.u0442u0435u0440u0430u043fu0435u0432u0442u0438u0447u0435u0441u043au0438 containing effective amount of an anti tuberculosis an antibiotic selected from the u0440u0438u0444u0430u0431u0443u0442u0438u043du0430 or u0440u0438u0444u0430u043cu043fu0438u0446u0438u043du0430,a therapeutic scheme (with u0443u0434u043bu0438u043du0435u043du043du044bu043cu0438 intervals between u0432u0432u0435u0434u0435u043du0438u044fu043cu0438 and in smaller doses).a pharmaceutical composition, in comparison with the prototypeprovides greater "u0437u0430u0433u0440u0443u0437u043au0443u00bb very essential tool in comparison with the prototype and higher antitubercular activity.
机译:本发明涉及药物领域,更具体地讲,用于治疗结核病的药物。更具体地,本发明涉及一种用于治疗结核病的药物组合物,其基于分散在 u0444 u0430 u0440 u043c u0430 u0446 u0435 u0432 u0442 u0438 u0447 u0435 u0441 u043a u0438固体脂质可接受的介质 u043d u0430 u043d u043e u0447 u0430 stitz,有效量的含 u0442 的抗结核药物u0435 u0440 u0430 u043f u0435 u0432 u0442 u0438 u0447 u0435 u0441 u043a u0438是指(选自 u0440 u0438 u0444 u0430 u0431 u0443 u0442 u0438 u043d的抗生素 u0430或 u0440 u0438 u0444 u0430 u043c u043f u0438 u0446 u0438 u043d u04d), u0441 u043e u0440 u0431 u0438 u0440 u0440 u043e u0432 u0430 u043d u043d脂质基质中的u043e u0433 u043e。 u043d u0430 u043d u043e u0447 u0430 u0441 u0442 u0438 u0446 u044b这样的脂质基质包含一个或多个 u0434 u043b u0438 u043d u043d u043e u0446 u0435 u 043f u043e u0447 u0435 u0447 u043d u044b u0445脂肪酸,胆固醇或其衍生物和 u0444 u043e u0441 u0444 u043e u043b u0438 u043f u043f u0438 u0434 u0430 u0444的复杂酯可以接受的治疗结核病的方法,包括在其上引入药物组合物。 u0442 u0435 u0440 u0430 u043f u0435 u0432 u0442 u0438 u0447 u0435 u0441 u043a u0438含有有效量的抗结核病,抗生素选自 u0440 u0438 u0444 u0430 u0431 u0443 u0442 u0438 u043d u0430或 u0440 u0438 u0444 u0430 u043c u043f u0438 u0446 u0438 u043d u0430是一种治疗方案(与 u0443 u0434 u043b u0438 u043d u0435 u043d u043d u044b u043c u0438在 u0432 u0432 u0435 u0434 u0435 u043d u043d u0438 u044f u043c u0438和较小剂量之间的间隔)。药物组合物,与原型相比与原型相比,它提供了更强大的工具,并且具有更高的抗结核活性,从而提供了更强大的工具。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号